Beijing, Beijing, China Related Funds
| Fund Name | Location |
| Admitad | Baden-Wurttemberg, Germany, Heilbronn |
| AI Fund | California, Palo Alto, United States |
| Checketts Partners Investment Fund | - |
| Crassets Investment | China, Shanghai |
| Elkstone | County Dublin, Dublin, Ireland |
| Futury Ventures | - |
| Global Health & Pharma | East Staffordshire, England, United Kingdom |
| Hacking Health Accelerator | Canada, Montréal, Quebec |
| HumanCo | New York, New York, United States |
| Liberty Financial | Australia, Melbourne, Victoria |
| Senderui Touzi | China, Guangdong, Shenzhen |
| Shanghai Elegant Investment | China, Shanghai |
| Solarisbank | Berlin, Berlin, Germany |
| Sunrise Strategic Partners | Boulder, Colorado, United States |
| Trend Discovery Capital Management | New York, New York, United States |
| Upshift Partners | California, San Francisco, United States |
| XLerateHealth | Kentucky, Louisville, United States |
| Zheke Huifu Chuang Tou | China, Hangzhou, Zhejiang |
| Zhonghui Guoji | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
San Sheng | 14 Mar 2018 | Beijing | |||
| $3M | 22 Dec 2017 | Beijing | |||
| 18 Oct 2017 | Beijing | ||||
Moby | $1M | 13 Sep 2017 | Shanghai, China | ||
| $3M | 13 Jun 2017 | China, Zhejiang | |||
91360 Med Tech | $463K | 03 Nov 2016 | Xuanwu District, Jiangsu, China | ||
Yijian Chuanmei | $1M | 02 Nov 2016 | Dongcheng District, Beijing, China | ||
| $463K | 02 Feb 2016 | China, Beijing | |||
| 30 Dec 2015 | China, Shanghai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
San Sheng | 14 Mar 2018 | Beijing | |||
| $3M | 22 Dec 2017 | Beijing | |||
| 18 Oct 2017 | Beijing | ||||
Moby | $1M | 13 Sep 2017 | Shanghai, China | ||
| $3M | 13 Jun 2017 | China, Zhejiang | |||
91360 Med Tech | $463K | 03 Nov 2016 | Xuanwu District, Jiangsu, China | ||
Yijian Chuanmei | $1M | 02 Nov 2016 | Dongcheng District, Beijing, China | ||
| $463K | 02 Feb 2016 | China, Beijing | |||
| 30 Dec 2015 | China, Shanghai |
